Adagio Therapeutics Inc
ADGI
Get informed when a big investor buys or sells
+ FollowMarket Cap$505.68M
Close$
Share Statistics
| Market cap | $505.68 Million |
|---|---|
| Enterprise Value | $353.99 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.3 |
| Beta | 0 |
| Outstanding Shares | 320,435,078 |
Return
| Return on Equity | -59.27% |
|---|---|
| Return on Assets | -49.04% |
| Return on Invested Capital | -59.90% |
Valuation & Multiples
| P/E Ratio | -2.45 |
|---|---|
| PEG | -1.21 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.07 |
| Enterprise Value to EBIT | -3.15 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Adagio Therapeutics Inc
2,021 employees